Jacobson Center for Clinical & Translational Research

Main Menu

/research/

Additional Information

 

Contact Us

Epilepsy Research Studies

Study Title:  A Phase 2 Multicenter Double-Blind Randomized Adjunctive Placebo Controlled Trial to Evaluate the Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures. (Identifier: NCT01866111)

Study Purpose:  This study is to evaluate the efficacy of YKP3089 in reducing seizure frequency when compared to baseline in subjects with partial onset seizures not fully controlled despite their treatment with 1 to 3 concomitant anti-epileptic drugs.

Principal Investigator: Imran Ali, M.D.

Study Coordinator: Shekhar Raj, for more information, please call 419-383-4293


Study Title:  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sage-547                          Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus.  (Identifier: NCT02477618)

Study Purpose:  This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in Super-Refractory Status Epilepticus (SRSE).

Principal Investigator: Imran Ali, M.D.

Study Coordinator: Shekhar Raj, for more information, please call 419-383-4293

Last Updated: 8/11/15